Developer docs
API playgroundTry for free, no card

Search company profiles

Sequani

Full company profile

uuid000nk38

Namestring
Sequani
Legal namestring
Sequani Limited
Websiteurl
sequani.com
Company typeenum
Private
Founded yearint
1982
Descriptiontext

Sequani is a UK-based, privately held contract research organization (CRO) specializing in non-clinical safety assessment for the pharmaceutical, crop protection, and chemical industries. Founded in the early 1980s and headquartered in Ledbury, Herefordshire, the company operates a purpose-built facility comprising 820m² of laboratory space and a 910m² modern vivarium, processing over 500,000 histology samples per year with a staff of 51–100. Sequani is structured around three service divisions — Drug Development, Crop Protection, and Chemical Safety — and offers an integrated portfolio covering general, genetic, reproduction, juvenile, and carcinogenicity toxicology, plus pathology, clinical pathology, bioanalysis, toxicokinetics/pharmacokinetics, formulation analysis, biomarkers, and SEND-compliant data services.

The company's core technology stack combines in vivo toxicology study execution under GLP (compliant with OECD, EPA, and JMAFF guidelines) with conventional bioanalytical instrumentation — Sciex LC-MS/MS, Roche cobas, Sysmex hematology analyzers, and Phoenix WinNonLin for PK/PD modeling. Differentiated capabilities include microsampling techniques (≤50 µL blood volumes) deployed across more than 100 studies, a pioneering cross-fostering juvenile toxicology approach reducing animal usage by more than 65% (with 70+ regulatory juvenile studies completed), and the SEND ASSURE service, which guarantees 100% consistency between SEND datasets and final study reports for FDA and PMDA submissions via a partnership with PointCross.

Sequani generates revenue through professional-services contracts on a project-by-project basis, with study fees negotiated based on study complexity, duration, and species used; pricing is not publicly disclosed. The go-to-market is direct enterprise sales supported by dedicated programme managers, with demand generation through industry conferences (SOT, EuroTox, British Toxicology Society), webinars (notably with Medicines Discovery Catapult), scientific publications, and a content-rich website. Customers are large pharmaceutical companies, crop protection product developers, and chemical manufacturers operating in EMEA, with global reach implied by marketing activity though only the UK is listed as an operating geography.

Short descriptiontext

Sequani is a UK-based non-clinical contract research organization providing GLP toxicology, bioanalysis, formulation, and pathology services to pharmaceutical, crop protection, and chemical companies for regulatory safety submissions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLedbury, United Kingdom
HQ citystring
Ledbury
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
non-clinical toxicology, contract research services, drug safety assessment, crop protection testing, chemical safety evaluation
Industry3 codes
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAE
GxP Audits & Supplier Qualification (GMP/GCP/GLP/GDP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code1 code
  • Testing Laboratories and Services541380
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Contract Research Organization (CRO) - Non-Clinical Toxicology
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

Sequani generates revenue through providing contract research services including toxicology studies, bioanalysis, formulation sciences, pathology, and pharmacokinetics/toxicokinetics services to pharmaceutical, crop protection, and chemical companies. Studies are conducted on a project-by-project basis with fees based on study complexity, duration, and species used.

Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1SEND ASSURE
Description

A turnkey service that thoroughly checks generated SEND (Standard for Exchange of Nonclinical Data) datasets against the final PDF Study Report, providing 100% guarantee of data consistency and submission quality.

sequani.com
Core offering1 text field

Sequani is a contract research organization (CRO) providing non-clinical safety assessment services to pharmaceutical, crop protection, and chemical companies. Services span toxicology studies (general, genetic, reproduction, juvenile, carcinogenicity), bioanalysis, formulation sciences, pathology, clinical pathology, toxicokinetics/pharmacokinetics, biomarkers, microsampling, and SEND regulatory data compliance, all delivered under GLP with OECD, EPA, and JMAFF guideline adherence from a custom-designed facility with co-located laboratory and vivarium space.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Animal usage reduction of more than 65% through cross-fostering approach
+2 more records
Product overview1 text field

Sequani operates as a contract research organization (CRO) providing non-clinical laboratory services across three divisions: Drug Development, Crop Protection, and Chemical Safety. The company offers an integrated service portfolio encompassing toxicology (general, genetic, reproduction, juvenile, carcinogenicity, investigative), pathology, clinical pathology, bioanalysis, formulation sciences, toxicokinetics/pharmacokinetics, biomarkers, and programme management. Specialized offerings include SEND ASSURE for CDISC data compliance, microsampling techniques for reduced animal use, and REACH regulatory services for chemical safety. Studies are conducted under GLP with OECD, EPA, and JMAFF guideline compliance. The service is delivered through purpose-built laboratory and vivarium facilities with dedicated study directors coordinating cross-functional scientific teams.

Product and service10 records
1Drug Development Services
CategoryCore Service Division - Pharmaceutical Drug Development
Description

Comprehensive non-clinical drug development services supporting all phases from lead optimization through Phase III, including toxicology, bioanalysis, pharmacokinetics, formulation sciences, pathology, clinical pathology, biomarkers, microsampling, safety pharmacology, and SEND regulatory submission support. Targeted at pharmaceutical companies developing drug candidates.

2Crop Protection Services
3Chemical Safety Services
4SEND ASSURE
5Reproduction Toxicology Studies
6Juvenile Toxicology Studies
7Carcinogenicity Studies
8REACH Regulation Services
9Bioanalysis Services
10Programme Management Service
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-06-10
Description

Collaborated on MDC Connects Webinar series presenting on nonclinical strategies for First in Man clinical trials, specifically on 'How to get your molecule into humans' with focus on developing nonclinical strategy and enhancing nonclinical efficiency.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2018-03-29
Description

Collaborative presentation at 2018 SOT conference with Ellegaard Minipigs comparing toxic response of mouse and minipig to novel anticancer drug. Ellegaard provides Göttingen Minipigs used in toxicology studies.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2018-03-29
Description

Collaborative presentation at 2018 SOT conference with Marshall BioResources alongside Ellegaard Minipigs on preclinical toxicology model comparison.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership for SEND ASSURE service providing turnkey validation of SEND datasets against regulatory requirements. PointCross eDataValidator is used alongside Pinnacle21 validation to ensure FDA Technical Conformance Guide compliance and Technical Rejection Criteria avoidance.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest global non-clinical CRO offering a broad portfolio of toxicology, reproductive toxicology, juvenile toxicology, and pathology services to pharma and agrochemical sponsors. Directly comparable to Sequani across most service lines but with materially greater scale, geographic reach, and integrated discovery-to-clinical offerings.

TypeDirect peer
Description

Major non-clinical CRO providing GLP toxicology, safety assessment, and bioanalysis for pharmaceutical and chemical clients. Overlaps Sequani's drug development, REACH, and SEND-related service portfolio with significantly larger capacity and global footprint.

TypeDirect peer
Description

Preclinical CRO with strong toxicology, reproductive toxicology, and research-models capabilities serving pharma and crop protection sponsors. Direct overlap with Sequani on rodent/non-rodent toxicology and reproduction studies.

TypeBroad incumbent
Description

Global CRO/CDMO with non-clinical safety assessment, bioanalysis, and SEND capabilities across pharma and agrochemical clients. Comparable service lines to Sequani but operating at significantly larger scale with broad geographic presence.

TypeBroad incumbent
Description

International testing laboratory group with extensive agrochemical, REACH, and pharmaceutical safety testing services. Overlaps Sequani on chemical safety, REACH, and crop protection toxicology testing through its agrochemical and pharma testing divisions.

TypeBroad incumbent
Description

Global testing, inspection and certification company with REACH and crop protection regulatory testing services. Comparable to Sequani's chemical safety and crop protection divisions, though as part of a much broader TIC portfolio.

TypeEmerging player
Description

Integrated CRO/CDMO offering non-clinical toxicology, DMPK, bioanalysis, and SEND services for pharma and agrochemical clients. Comparable to Sequani's toxicology and bioanalysis capabilities but with broader integrated discovery services.

TypeEmerging player
Description

Preclinical CRO providing toxicology, bioanalysis, and SEND data services for biopharma sponsors. Overlaps Sequani on SEND ASSURE / regulatory data packages and GLP toxicology for smaller biotech clients.

TypeDirect peer
Description

Preclinical CRO with non-clinical toxicology, SEND, and agrochemical regulatory testing services. Direct overlap with Sequani on GLP toxicology, SEND data services, and crop protection safety studies.

10CiToxLAB (now part of Charles River)
TypeDirect peer
Description

Former independent European non-clinical CRO with strong general toxicology, reproduction, and inhalation toxicology capabilities; now part of Charles River but historically a direct peer to Sequani on European pharma and agrochemical safety work.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sequani

Contract Research Organization (CRO) - Non-Clinical Toxicologysequani.com

Sequani is a UK-based non-clinical contract research organization providing GLP toxicology, bioanalysis, formulation, and pathology services to pharmaceutical, crop protection, and chemical companies for regulatory safety submissions.

What Sequani does

Sequani is a UK-based, privately held contract research organization (CRO) specializing in non-clinical safety assessment for the pharmaceutical, crop protection, and chemical industries. Founded in the early 1980s and headquartered in Ledbury, Herefordshire, the company operates a purpose-built facility comprising 820m² of laboratory space and a 910m² modern vivarium, processing over 500,000 histology samples per year with a staff of 51–100. Sequani is structured around three service divisions — Drug Development, Crop Protection, and Chemical Safety — and offers an integrated portfolio covering general, genetic, reproduction, juvenile, and carcinogenicity toxicology, plus pathology, clinical pathology, bioanalysis, toxicokinetics/pharmacokinetics, formulation analysis, biomarkers, and SEND-compliant data services.

The company's core technology stack combines in vivo toxicology study execution under GLP (compliant with OECD, EPA, and JMAFF guidelines) with conventional bioanalytical instrumentation — Sciex LC-MS/MS, Roche cobas, Sysmex hematology analyzers, and Phoenix WinNonLin for PK/PD modeling. Differentiated capabilities include microsampling techniques (≤50 µL blood volumes) deployed across more than 100 studies, a pioneering cross-fostering juvenile toxicology approach reducing animal usage by more than 65% (with 70+ regulatory juvenile studies completed), and the SEND ASSURE service, which guarantees 100% consistency between SEND datasets and final study reports for FDA and PMDA submissions via a partnership with PointCross.

Sequani generates revenue through professional-services contracts on a project-by-project basis, with study fees negotiated based on study complexity, duration, and species used; pricing is not publicly disclosed. The go-to-market is direct enterprise sales supported by dedicated programme managers, with demand generation through industry conferences (SOT, EuroTox, British Toxicology Society), webinars (notably with Medicines Discovery Catapult), scientific publications, and a content-rich website. Customers are large pharmaceutical companies, crop protection product developers, and chemical manufacturers operating in EMEA, with global reach implied by marketing activity though only the UK is listed as an operating geography.

Sequani firmographics

Firmographics
Name
Sequani
Legal name
Sequani Limited
Website
https://sequani.com
Company type
Private
Founded year
1982
Operating status
Operating
Headcount range
101–250 employees
Short description
Sequani is a UK-based non-clinical contract research organization providing GLP toxicology, bioanalysis, formulation, and pathology services to pharmaceutical, crop protection, and chemical companies for regulatory safety submissions.
Ownership category
akta.pro rank

Sequani industry classification

Industry
Product category
Contract Research Organization (CRO) - Non-Clinical Toxicology
NAICS
Testing Laboratories and Services (541380)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAE
GxP Audits & Supplier Qualification (GMP/GCP/GLP/GDP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Non-clinical toxicology
  • Contract research services
  • Drug safety assessment
  • Crop protection testing
  • Chemical safety evaluation

Where Sequani is headquartered

Location

Headquarters

HQ city
Ledbury
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Sequani business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Research Services: Sequani generates revenue through providing contract research services including toxicology studies, bioanalysis, formulation sciences, pathology, and pharmacokinetics/toxicokinetics services to pharmaceutical, crop protection, and chemical companies. Studies are conducted on a project-by-project basis with fees based on study complexity, duration, and species used.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Sequani product offering

Product offering

Core offering

Sequani is a contract research organization (CRO) providing non-clinical safety assessment services to pharmaceutical, crop protection, and chemical companies. Services span toxicology studies (general, genetic, reproduction, juvenile, carcinogenicity), bioanalysis, formulation sciences, pathology, clinical pathology, toxicokinetics/pharmacokinetics, biomarkers, microsampling, and SEND regulatory data compliance, all delivered under GLP with OECD, EPA, and JMAFF guideline adherence from a custom-designed facility with co-located laboratory and vivarium space.

Product overview

Sequani operates as a contract research organization (CRO) providing non-clinical laboratory services across three divisions: Drug Development, Crop Protection, and Chemical Safety. The company offers an integrated service portfolio encompassing toxicology (general, genetic, reproduction, juvenile, carcinogenicity, investigative), pathology, clinical pathology, bioanalysis, formulation sciences, toxicokinetics/pharmacokinetics, biomarkers, and programme management. Specialized offerings include SEND ASSURE for CDISC data compliance, microsampling techniques for reduced animal use, and REACH regulatory services for chemical safety. Studies are conducted under GLP with OECD, EPA, and JMAFF guideline compliance. The service is delivered through purpose-built laboratory and vivarium facilities with dedicated study directors coordinating cross-functional scientific teams.

Differentiator

Problem solved

Functional benefit

Brands

  • SEND ASSURE: A turnkey service that thoroughly checks generated SEND (Standard for Exchange of Nonclinical Data) datasets against the final PDF Study Report, providing 100% guarantee of data consistency and submission quality.

Products and services

  • Drug Development Services Comprehensive non-clinical drug development services supporting all phases from lead optimization through Phase III, including toxicology, bioanalysis, pharmacokinetics, formulation sciences, pathology, clinical pathology, biomarkers, microsampling, safety pharmacology, and SEND regulatory submission support. Targeted at pharmaceutical companies developing drug candidates.
  • Crop Protection Services
  • Chemical Safety Services
  • SEND ASSURE
  • Reproduction Toxicology Studies
  • Juvenile Toxicology Studies
  • Carcinogenicity Studies
  • REACH Regulation Services
  • Bioanalysis Services
  • Programme Management Service

Quantifiable outcome

  • Animal usage reduction of more than 65% through cross-fostering approach
  • +2 more outcomes

Companies that use Sequani

Customer profile

Segments3 records

Ideal customer profiles3 records

Sequani technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Sequani partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Medicines Discovery Catapult (MDC)coreStrategic or Co-development Partner · 10 June 2020Collaborated on MDC Connects Webinar series presenting on nonclinical strategies for First in Man clinical trials, specifically on 'How to get your molecule into humans' with focus on developing nonclinical strategy and enhancing nonclinical efficiency.
  • Ellegaard MinipigsminorStrategic or Co-development Partner · 29 March 2018Collaborative presentation at 2018 SOT conference with Ellegaard Minipigs comparing toxic response of mouse and minipig to novel anticancer drug. Ellegaard provides Göttingen Minipigs used in toxicology studies.
  • Marshall BioResourcesminorStrategic or Co-development Partner · 29 March 2018Collaborative presentation at 2018 SOT conference with Marshall BioResources alongside Ellegaard Minipigs on preclinical toxicology model comparison.
  • PointCrosscoreTechnology or IntegrationPartnership for SEND ASSURE service providing turnkey validation of SEND datasets against regulatory requirements. PointCross eDataValidator is used alongside Pinnacle21 validation to ensure FDA Technical Conformance Guide compliance and Technical Rejection Criteria avoidance.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Sequani competitors and assessment

Company assessment

Direct peers

  • Charles River Laboratories: Largest global non-clinical CRO offering a broad portfolio of toxicology, reproductive toxicology, juvenile toxicology, and pathology services to pharma and agrochemical sponsors. Directly comparable to Sequani across most service lines but with materially greater scale, geographic reach, and integrated discovery-to-clinical offerings.
  • Labcorp Drug Development (Fortrea): Major non-clinical CRO providing GLP toxicology, safety assessment, and bioanalysis for pharmaceutical and chemical clients. Overlaps Sequani's drug development, REACH, and SEND-related service portfolio with significantly larger capacity and global footprint.
  • Inotiv (formerly Envigo): Preclinical CRO with strong toxicology, reproductive toxicology, and research-models capabilities serving pharma and crop protection sponsors. Direct overlap with Sequani on rodent/non-rodent toxicology and reproduction studies.
  • Smithers (Smithers Avanza / Viscient): Preclinical CRO with non-clinical toxicology, SEND, and agrochemical regulatory testing services. Direct overlap with Sequani on GLP toxicology, SEND data services, and crop protection safety studies.
  • CiToxLAB (now part of Charles River): Former independent European non-clinical CRO with strong general toxicology, reproduction, and inhalation toxicology capabilities; now part of Charles River but historically a direct peer to Sequani on European pharma and agrochemical safety work.

Broad incumbents

  • WuXi AppTec: Global CRO/CDMO with non-clinical safety assessment, bioanalysis, and SEND capabilities across pharma and agrochemical clients. Comparable service lines to Sequani but operating at significantly larger scale with broad geographic presence.
  • Eurofins Scientific: International testing laboratory group with extensive agrochemical, REACH, and pharmaceutical safety testing services. Overlaps Sequani on chemical safety, REACH, and crop protection toxicology testing through its agrochemical and pharma testing divisions.
  • SGS: Global testing, inspection and certification company with REACH and crop protection regulatory testing services. Comparable to Sequani's chemical safety and crop protection divisions, though as part of a much broader TIC portfolio.

Emerging players

  • Pharmaron: Integrated CRO/CDMO offering non-clinical toxicology, DMPK, bioanalysis, and SEND services for pharma and agrochemical clients. Comparable to Sequani's toxicology and bioanalysis capabilities but with broader integrated discovery services.
  • Bionova Scientific: Preclinical CRO providing toxicology, bioanalysis, and SEND data services for biopharma sponsors. Overlaps Sequani on SEND ASSURE / regulatory data packages and GLP toxicology for smaller biotech clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Sequani social profiles

Digital presence

Sequani financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sequani leadership team

Management profile

Number of profiles

Profiles2 records

Sequani funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sequani M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sequani

What does Sequani do?

Sequani is a contract research organization (CRO) providing non-clinical safety assessment services to pharmaceutical, crop protection, and chemical companies. Services span toxicology studies (general, genetic, reproduction, juvenile, carcinogenicity), bioanalysis, formulation sciences, pathology, clinical pathology, toxicokinetics/pharmacokinetics, biomarkers, microsampling, and SEND regulatory data compliance, all delivered under GLP with OECD, EPA, and JMAFF guideline adherence from a custom-designed facility with co-located laboratory and vivarium space.

Is Sequani a public or private company?

Sequani is a private company. It is classified as unknown and is currently operating.

When was Sequani founded?

Sequani was founded in 1982. It employs 101 to 250 people.

Where is Sequani based?

Sequani is headquartered in Ledbury, United Kingdom, in the Europe region.

How does Sequani make money?

One revenue line is on record: contract Research Services.

Who are Sequani's main competitors?

Direct peers on record are Charles River Laboratories, Labcorp Drug Development (Fortrea), Inotiv (formerly Envigo), Smithers (Smithers Avanza / Viscient) and CiToxLAB (now part of Charles River). Broad incumbents are WuXi AppTec, Eurofins Scientific and SGS. Emerging players are Pharmaron and Bionova Scientific.

Does Sequani have an API?

No public API is recorded for Sequani.

What industry is Sequani in?

Sequani's product category is Contract Research Organization (CRO) - Non-Clinical Toxicology. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAKAK, Laboratory Quality & GLP/GCLP Compliance. Its NAICS code is 541380 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales